FDA has not appropriately debarred a number of individuals and pharmaceutical companies convicted of crimes from participation in the agency approv

The Bush administration over the next several months will issue new Medicaid rules that would shift billions of dollars in costs to the states, after studies from the

An increasingly aging U.S. population is expected to put additional strain on the costs of government-sponsored programs, such as Social Security and Medicare, even as the rising number of immigr

The Department of Labor on Monday published proposed rules that would require employees to request Family and Medical Leave Act leave in advance in

The Office of Minority Health at HHS and the

Hayes, Inc. launches Genetic Test Evaluation (GTE), a subscription-based, online service that provides insurers, hospitals and policy makers objective insight into the clinical utility of genetic

Kamada (TASE:KMDA), a biopharmaceutical company which develops, manufactures and markets specialty life-saving therapeutics, announces that the company will soon start phase II clinical trials wit

Unigene Laboratories, Inc. (OTCBB: UGNE) has initiated a Phase I/II clinical study in the U.S. with its proprietary formulation of oral calcitonin for the treatment of osteoporosis. Twenty-four he

CytRx Corporation (Nasdaq:CYTR), a biopharmaceutical company engaged in the development and commercialization of human therapeutics, announced receipt of a written correspondence from the U.S. Fo

Molecules That Changed the World, written by bestselling author and world-renowned chemist, Professor K.C. Nicolaou, and Dr. Tamsyn Montagnon, takes an in-depth look at some of the most famous and

Cook Medical announced enrollment of the first U.S. patient in the STABLE global clinical trial designed to evaluate the Cook Zenith® Dissection Endovascular System for the treatment of Type B

Global Research Services, LLC (GRS) announces the successful U.S. launch of a clinical trial management on-line training initiative in collaboration with the University of Rochester Medical Center

Presidio Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing novel, small molecule compounds for the treatment of HIV-1 and HCV and Numerate, Inc.,

The potential threat that HIV/AIDS poses to the strength of the private sector in Russia is not as high on the corporate agenda as it should be, Daniel Kashnitsky -- an associate at

Public health officials working to prevent the spread of HIV nationwide have to work with one hand tied behind their backs because Congress has banned the use of federal funds for needle-exchan

A network of people living with HIV/AIDS, cancer and other conditions on Saturday gathered at the office of Chaiya Sasomsap, Thailand's minister of public health, to protest his decision to revie

Health Dialog Services Corporation today announced it has been selected by the Centers for Medicare and Medicaid Services (CMS) to provide health and wellness support to more than 17,000 Medicare

Some advocates in Massachusetts are lobbying to increase funding for HIV/AIDS services in the state by at least $6 million, the

The AIDS Information Center, Text to Change and

The reliability and accuracy of coagulation test results depend upon a variety of variables, including anticoagulant volume and concentration, type of tube additive, duration and temperature of sp

The following highlights recent news about programs related to human papillomavirus vaccines and sex education.HPV Kentucky: The House

The following highlights state legislative action on abortion and human embryonic stem cell-related bills. Abortion Kentucky: On Thurs

A new study published in Cancer reports that thelikelihoodof patients' obtaining colorectal cancer screenings is dependent onhealth care providers. Dr. Melissa M. Farmer of Veterans Aff

Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) announced that the US Food and Drug Administration (FDA) has granted an approval to the Company's Abbreviated New Drug Application (ANDA) for Hydrocodone

Members of the National Federation of the Blind (NFB) will testify before the Senate Judicial Proceedings Committee regarding the extreme danger silent hybrid cars pose to the blind, as well as ot

SourceMedical, the leading provider of outpatient information solutions collectively serving 6,000 ambulatory surgery centers, surgical hospitals, and rehabilitation clinics nationwide, announced

The American College of Allergy, Asthma & Immunology (ACAAI) has published for the first time a special supplement to its medical journal, Annals of Allergy, Asthma and Immunology, titled

Kinetic Concepts, Inc. (NYSE:KCI) announced the final efficacy results of a randomized controlled clinical trial (RCT) on the clinical efficacy of KCI's V.A.C.(R) System negative pressure wound th

Diamyd Medical (NASDAQ:DMYDY) (STO:DIAMB) announced that it has received one FDA question relating to the US Phase III IND application for Diamyd® in treatment of type 1 diabetes. The question

Julie Bentley has now taken her position as fpa's new Chief Executive Officer (CEO). Julie was formerly CEO of personal safety charity The Suzy Lamplugh Trust. Her professional